• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.39% Nasdaq Up 0.28%

    Avalanche Biotechnologies, Inc. (AAVL)

    -NasdaqGM
    4.13 Down 0.70(14.49%) 3:29PM EDT - Nasdaq Real Time Price
    Prev Close:4.83
    Open:4.70
    Bid:4.10 x 4400
    Ask:4.11 x 1200
    1y Target Est:11.50
    Beta:N/A
    Earnings Date:May 11 - May 16 (Est.)
    Day's Range:4.10 - 4.83
    52wk Range:4.00 - 41.60
    Volume:455,457
    Avg Vol (3m):360,381
    Market Cap:111.47M
    P/E (ttm):N/A
    EPS (ttm):-1.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AAVL

    Comparison

    Symbol% ChgMkt Cap
    AAVLDown 14.49%111.47M
    REGNDown 1.70%38.82B
    AGNDown 3.46%80.23B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):66.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.77
    Quarterly EPS Est (Mar-16) :-0.39
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Avalanche Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback